British Journal of Clinical Pharmacology logo Wiley-Blackwell logo

Publisher: Wiley-Blackwell

Related content
Volume 56, Number 3, September 2003

< previous issue | all issues | next issue >

Free Content Features of this month's Journal
pp. 247-248(2)
Author: Aronson J.K.

Free Content The clinical pharmacology of ageing
pp. 249-253(5)
Author: Swift C.G.

Free Content The cardiovascular system
pp. 254-260(7)
Authors: Moore A.; Mangoni A.A.; Lyons D.; Jackson S.H.D.

Free Content Clinical pharmacology of old age syndromes
pp. 261-272(12)
Authors: Broadhurst C.; Wilson K.C.M.; Kinirons M.T.; Wagg A.; Dhesi J.K.

Free Content Diagnostic methods for Helicobacter pylori detection and eradication
pp. 273-283(11)
Authors: Goddard A.F.; Logan R.P.H.

Free Content Determining small bowel integrity following drug treatment
pp. 284-291(8)
Authors: Smale S.; Bjarnason I.

Free Content Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men
pp. 297-304(8)
Authors: Olubodun J.O.; Ochs H.R.; von Moltke L.L.; Roubenoff R.; Hesse L.M.; Harmatz J.S.; Shader R.I.; Greenblatt D.J.

Free Content CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide
pp. 305-314(10)
Authors: Bidstrup T.B.; Bjørnsdottir I.; Sidelmann U.G.; Thomsen M.S.; Hansen K.T.

Free Content Haloperidol plasma concentration in Japanese psychiatric subjects with gene duplication of CYP2D6
pp. 315-320(6)
Authors: Ohnuma T.; Shibata N.; Matsubara Y.; Arai H.

Free Content Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans
pp. 321-326(6)
Authors: Graff J.; Klinkhardt U.; Westrup D.; Kirchmaier C.M.; Breddin H.K.; Harder S.

Free Content Tacrolimus dose requirement in renal transplant recipients is significantly higher when used in combination with corticosteroids
pp. 327-330(4)
Authors: Hesselink D.A.; Ngyuen H.; Wabbijn M.; Gregoor P.J.H.S.; Steyerberg E.W.; van Riemsdijk I.C.; Weimar W.; van Gelder T.

Free Content Allele and genotype frequency of CYP2C19 in a Tamilian population
pp. 331-333(3)
Authors: Adithan C.; Gerard N.; Vasu S.; Rosemary J.; Shashindran C.H.; Krishnamoorthy R.

Free Content Interferon-bgr treatment in patients with multiple sclerosis does not alter CYP2C19 or CYP2D6 activity
pp. 337-340(4)
Authors: Hellman K.; Roos E.; Österlund A.; Wahlberg A.; Gustafsson L.L.; Bertilsson L.; Fredrikson S.

Free Content Identification of a novel splice-site mutation in the CYP1A2 gene
pp. 341-344(4)
Authors: Allorge D.; Chevalier D.; Lo-Guidice J-M.; Cauffiez C.; Suard F.; Baumann P.; Eap C.B.; Broly F.

Free Content The Forensic Pharmacology of Drugs of Abuse
pp. 345-346(2)
Author: Flanagan R.J.

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page